AVEO Oncology
AVEO
#7113
Rank
A$0.78 B
Marketcap
A$22.55
Share price
0.00%
Change (1 day)
159.13%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -A$40.76 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are A$94.31 Million. In 2021 the company made an earning of -A$80.18 Million a decrease over its 2020 earnings that were of -A$53.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -A$40.76 Million-49.16%
2021 -A$80.18 Million49.9%
2020 -A$53.49 Million-479.04%
2019 A$14.11 M-276.17%
2018 -A$8.02 Million-91.79%
2017 -A$97.59 Million142.38%
2016 -A$40.27 Million78.51%
2015 -A$22.56 Million-71.55%
2014 -A$79.28 Million-50.72%
2013 -A$0.17 Billion-4.88%
2012 -A$0.17 Billion-426.29%
2011 A$51.83 M-159.85%
2010 -A$86.62 Million35.33%
2009 -A$64.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
A$2.86 B-6,656.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.73 B-17,817.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-A$3.4 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.07 B-27,762.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$33.82 B-77,594.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.39 B-28,489.41%๐Ÿ‡บ๐Ÿ‡ธ USA